PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Midas International FZE

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Midas International Strikes Venture Capital Deal with Orphan Drug Company - Dubai based investment firm takes position in promising U.S. biotech industry companies pursuing cures for untreated ailments - MidasWorldwide.com
Midas International Strikes Venture Capital Deal with Orphan Drug Company

 

NewswireToday - /newswire/ - Dubai, UAE, United Arab Emirates, 2008/11/13 - Dubai based investment firm takes position in promising U.S. biotech industry companies pursuing cures for untreated ailments - MidasWorldwide.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Midas International announced today that it has come to an agreement for up to $35 million in venture capital financing for two separate companies involved in the development of orphan drugs (Drugs for diseases that afflict small numbers of people). At this time details of the agreements were not disclosed, however it has been disclosed that the first round of funding would come immediately from Midas International with the later rounds coming from a consortium of their clients.

“Midas International has long supported the biotech industry. We believe that not only is it the right thing to do as global citizens, but from a business perspective as well,” said Kenneth Emerson, Director of Business development. “Several years ago we funded a small biotech firm in the U.S. that was developing a drug to protect the central nervous system. That drug is now used in treatments of more than a dozen diseases including Multiple Sclerosis.”

The companies that Midas has agreed to fund will both be receiving matching grants from a U.S. Foundation. The Dollar for Dollar agreement allows companies to effectively pursue treatments to ailments that often go untreated. Midas in return for its early round funding efforts will have a seat on the board of both companies and a right of first refusal on certain next steps the companies may take. The business model for investment into Orphan Drugs has been in effect since the 1983 Orphan Drug Act in the US granted special patent rights. Similar laws protect and promote this vital research and the drugs that are developed as a result in the EU.

Midas International, FZE (midasworldwide.com) is an investment banking, financial consulting and brokerage firm offering investment solutions, asset allocation strategies and analysis on equities and fixed income securities. The Dubai based investment firm has satellite offices in Hong Kong, London and Sydney.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Midas International FZE

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Financial/Legal/Venture articles,
CATCH Visitors via Your Competitors Announcements!


Midas International Strikes Venture Capital Deal with Orphan Drug Company

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Andy Scofield - MidasWorldwide.com 
+971 4 509 6841 ascofield[.]midasworldwide.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Midas International FZE securities in any jurisdiction including any other companies listed or named in this release.

Financial/Legal/Venture via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Midas International FZE / Company Profile


Read Financial/Legal/Venture Most Recent Related Newswires:

Societe Generale Named ‘Distinguished Provider of Transaction Banking Services’ by FImetrix
ALM Wins 2 Awards at 2017 Jesse H. Neal Awards
ALM’s ThinkAdvisor Launches Life/Health Channel
The National Law Journal Unveils Monthly Print Magazine
Societe Generale Selects HPD Software to Support its International Factoring Expansion
GE Closes Sale of Consumer Finance Business in France - Last Major Closing of GE Capital Exit Plan
Lazard Global Listed Infrastructure Fund Wins Two Lipper Fund Awards
Global Brands List of 2017 Awarded Elite Capital & Co. the Best Financial Brand in United Kingdom
FTI Consulting Receives Recognition in the Legal Industry
FinTech Start-ups Disrupt Business Models, Customer Engagement and Financial Services Delivery in Europe Finds Frost & Sullivan
Elite Capital & Co. Limited Signs Deal with ACB Investments Holding
LexisNexis® Business Insight Solutions Expands Risk Management Portfolio with New Risk Media Monitoring Solution
GE to Sell Shares in Hyundai Card Co. to Hyundai Commercial, Affinity Equity Partners and Other Investors
Societe Generale Named Best Trade Finance Provider in Western Europe and Emerging Markets by Global Finance
Frost & Sullivan Sees Strong IPO Momentum on ASX in 2017 - Strengthens Independent Market Research for IPO's team in Australia

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)